<ul><li>Brooklyn Health secures $6.5M in seed funding led by HealthX and other investors to expand its AI-powered precision for clinical trial endpoints.</li><li>The funding coincides with the launch of their new electronic clinical outcome assessment (eCOA) solution, Willis, which automates legacy services through AI for Central Nervous System (CNS) clinical trials.</li><li>Brooklyn Health aims to address the measurement crisis in neurology and psychiatry by providing accurate, sensitive, and objective measures of mental health, lowering barriers for drug discovery and enabling precision care.</li><li>Willis, Brooklyn Health's platform, uses AI to review clinical interview quality and score accuracy, providing real-time feedback for clinicians and enhanced data quality visibility for pharmaceutical sponsors.</li></ul>

Brooklyn Health Secures $6.5M to Expand AI-Powered Precision for Clinical Trial Endpoints

Discover more